MedTrace Logo

Effect of Recreational Play Activities on Anxiety in Children Receiving Chemotherapy and Their Parents

NCT07348900 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-07-24

No results posted yet for this study

Summary

This single-group pretest-posttest study evaluated changes in anxiety levels among children undergoing inpatient chemotherapy and their parents following nurse-led recreational play activities. Thirty-one child-parent pairs completed the study. Child anxiety was assessed using the Children's State Anxiety Scale, and parent anxiety was assessed using the State Anxiety Inventory Form-I immediately before and immediately after the recreational play intervention.

Conditions

Interventions

BEHAVIORAL

Nurse-Led Recreational Play Activities

Children undergoing inpatient chemotherapy participated with one parent in nurse-led recreational play activities conducted in the clinic playroom after scheduled treatment. The available activities included puzzles, Lego and model-building games, puppet-making and puppet play, storytelling, drawing, origami, and mandala coloring. Children selected activities according to their preferences, age, clinical condition, and attention span. Parents were encouraged to participate when appropriate. The recreational play activities lasted approximately 30-60 minutes. Child and parent anxiety levels were assessed immediately before and immediately after the intervention.

Sponsors & Collaborators

  • Akdeniz University

    lead OTHER

Principal Investigators

  • Şule Şenol, PhD · Akdeniz Üniversitesi Hemşirelik Fakültesi

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-15
Primary Completion
2025-05-07
Completion
2025-05-07

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07348900 on ClinicalTrials.gov